Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
McKesson
Harvard Business School
Johnson and Johnson
Dow

Last Updated: May 24, 2022

DrugPatentWatch Database Updates: New Patent Delistings


✉ Email this page to a colleague

« Back to Dashboard

DrugPatentWatch Database Updates: New Patent Delistings

These are patents which have been reported by the FDA since the last major update; they are not yet in the main database.
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Usecode Patented / Exclusive Use
Allergan COMBIGAN brimonidine tartrate; timolol maleate SOLUTION/DROPS 021398 Oct 30, 2007 RX Yes See Plans and Pricing See Plans and Pricing
Array Biopharma Inc MEKTOVI binimetinib TABLET 210498 Jun 27, 2018 RX Yes See Plans and Pricing See Plans and Pricing
Horizon DUEXIS famotidine; ibuprofen TABLET 022519 Apr 23, 2011 RX Yes See Plans and Pricing See Plans and Pricing
Allergan RESTASIS cyclosporine EMULSION 050790 Dec 23, 2002 RX Yes See Plans and Pricing See Plans and Pricing
Allergan RESTASIS cyclosporine EMULSION 050790 Dec 23, 2002 RX Yes See Plans and Pricing See Plans and Pricing U-1479 INCREASE TEAR PRODUCTION TO TREAT PATIENTS WITH KERATOCONJUNCTIVITIS SICCA (DRY EYE).
Allergan RESTASIS cyclosporine EMULSION 050790 Dec 23, 2002 RX Yes See Plans and Pricing See Plans and Pricing
Allergan RESTASIS cyclosporine EMULSION 050790 Dec 23, 2002 RX Yes See Plans and Pricing See Plans and Pricing U-1483 INCREASE TEAR PRODUCTION IN PATIENTS WITH KERATOCONJUNCTIVITIS SICCA (DRY EYE).
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Type >RLD >Patent No. >Patent Expiration >Usecode >Patented / Exclusive Use

Subscribe to access the full database, or Sign up for a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Moodys
Baxter
McKinsey
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2022 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2022 - 2023
 NCE-1 Patent Challenge Dates 2022 - 2023
 ClinicalTrialExchange - Connecting volunteers and trials
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2022, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group